Baxter Healthcare Corp. recalls PrismaSate BGK2/0 Dialysis Solution for Continuous Renal Replacement Therapy
- Recall date
- May 23, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-2049-2016
- FDA classification
- Class II
- Brand / firm
- Baxter Healthcare Corp.
- Sold / distributed
- Distributed to Columbia and the following US states: AZ, CA, CO, DE, FL, GA, IA, ID, IL, IN, KY, MA, MD, MI, MN, MO, MS, NC, ND, NE, NJ, NV, NY, OH, OR, PA, TN, TX, UT, VA, WA, WI
Why it was recalled
Presence of leaks near top of the PrismaSate bags
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
PrismaSate BGK2/0 Dialysis Solution for Continuous Renal Replacement Therapy
Get recall alerts
Free email alert whenever Baxter Healthcare Corp. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Baxter Healthcare Corp.